pipobroman has been researched along with Leukemia, Monocytic, Acute in 1 studies
Pipobroman: An antineoplastic agent that acts by alkylation.
pipobroman : An N-acylpiperazine that is piperazine in which each of the nitrogens has been acylated by a 3-bromopropionoyl group. An anti-cancer drug.
Leukemia, Monocytic, Acute: An acute myeloid leukemia in which 80% or more of the leukemic cells are of monocytic lineage including monoblasts, promonocytes, and MONOCYTES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A trial was conducted between 1970 and 1981 with pipobroman (PB) in 100 consecutive patients with polycythemia vera (PV), followed for a median time of 60 months, to evaluate the efficacy of this drug and assess the risk of acute leukemia." | 9.05 | Efficacy trial of pipobroman in polycythemia vera and incidence of acute leukemia. ( Bernasconi, C; Brusamolino, E; Canevari, A; Salvaneschi, L, 1984) |
| "A trial was conducted between 1970 and 1981 with pipobroman (PB) in 100 consecutive patients with polycythemia vera (PV), followed for a median time of 60 months, to evaluate the efficacy of this drug and assess the risk of acute leukemia." | 5.05 | Efficacy trial of pipobroman in polycythemia vera and incidence of acute leukemia. ( Bernasconi, C; Brusamolino, E; Canevari, A; Salvaneschi, L, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brusamolino, E | 1 |
| Salvaneschi, L | 1 |
| Canevari, A | 1 |
| Bernasconi, C | 1 |
1 trial available for pipobroman and Leukemia, Monocytic, Acute
| Article | Year |
|---|---|
Efficacy trial of pipobroman in polycythemia vera and incidence of acute leukemia.
Topics: Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Leukemia, Monocytic, Acute; Leukemia, M | 1984 |